Literature DB >> 23294496

Self-reported health promotion and disability progression in multiple sclerosis.

Marie Beatrice D'hooghe1, Guy Nagels, Jacques De Keyser, Patrick Haentjens.   

Abstract

BACKGROUND: Health behavior may be associated with disability progression in multiple sclerosis (MS).
OBJECTIVES: To investigate health-promoting behavior as measured by the Health-Promoting Lifestyle Profile II, which includes the subscales of health responsibility, physical activity, nutrition, spiritual growth, interpersonal relationships and stress management.
METHODS: We conducted a cross-sectional survey among individuals with MS, registered by the Flemish MS society, Belgium. Scores for the total scale and subscales were categorized into quintiles. A time-to-event analysis and Cox proportional hazard regression were performed with time to Expanded Disability Status Score (EDSS) of 6 (requires a cane) as an outcome measure. Hazard ratios for the time from onset and the time from birth were adjusted for gender, age at onset and immunomodulatory treatment. The first category was the reference group (first quintile).
RESULTS: Data on 1372 respondents with definite MS were collected. Subjects with relapsing onset MS and higher scores for overall health-promoting behavior, and the subscales of physical activity, nutrition and spiritual growth, had a reduced risk of reaching EDSS 6 compared to the reference group. No associations were found for the subscales of health responsibility, stress management and interpersonal relations. In progressive onset MS, no significant associations were obtained.
CONCLUSION: Our study shows an association of self-reported health promoting behavior with disability progression in subjects with relapsing onset MS.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23294496     DOI: 10.1016/j.jns.2012.12.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Stress in multiple sclerosis: review of new developments and future directions.

Authors:  Jesus Lovera; Tara Reza
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

2.  Selected health behaviors moderate the progression of functional limitations in persons with multiple sclerosis: Eleven years of annual follow-up.

Authors:  Alexa K Stuifbergen; Shelley Blozis; Heather Becker; Tracie Harrison; Vicki Kullberg
Journal:  Disabil Health J       Date:  2016-01-28       Impact factor: 2.554

3.  Health outcomes and adherence to a healthy lifestyle after a multimodal intervention in people with multiple sclerosis: Three year follow-up.

Authors:  Claudia H Marck; Alysha M De Livera; Chelsea R Brown; Sandra L Neate; Keryn L Taylor; Tracey J Weiland; Emily J Hadgkiss; George A Jelinek
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

Review 4.  Review of Two Popular Eating Plans within the Multiple Sclerosis Community: Low Saturated Fat and Modified Paleolithic.

Authors:  Terry L Wahls; Catherine A Chenard; Linda G Snetselaar
Journal:  Nutrients       Date:  2019-02-07       Impact factor: 5.717

5.  Comparing Health Promotion and Quality of Life in People with Progressive Versus Nonprogressive Multiple Sclerosis.

Authors:  Wenhui Zhang; Heather Becker; Alexa Stuifbergen
Journal:  Int J MS Care       Date:  2020-10-27

6.  The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results.

Authors:  Michelle Ploughman; Serge Beaulieu; Chelsea Harris; Stephen Hogan; Olivia J Manning; Penelope W Alderdice; John D Fisk; A Dessa Sadovnick; Paul O'Connor; Sarah A Morrow; Luanne M Metz; Penelope Smyth; Nancy Mayo; Ruth Ann Marrie; Katherine B Knox; Mark Stefanelli; Marshall Godwin
Journal:  BMJ Open       Date:  2014-07-10       Impact factor: 2.692

7.  Psychosocial and Medical Determinants of Health-related Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Isaac Rahimian Boogar; Siavash Talepasand; Mohammad Jabari
Journal:  Noro Psikiyatr Ars       Date:  2018-03-19       Impact factor: 1.339

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.